Escherichia coli infections and hemolytic-uremic syndrome.
作者信息
Cimolai N
出版信息
CMAJ. 2001 May 15;164(10):1405-6.
Abstract
摘要
相似文献
1
Escherichia coli infections and hemolytic-uremic syndrome.大肠杆菌感染与溶血尿毒综合征。
CMAJ. 2001 May 15;164(10):1405-6.
2
Escherichia coli infections and hemolytic-uremic syndrome.大肠杆菌感染与溶血尿毒综合征。
CMAJ. 2001 May 15;164(10):1406.
3
Risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections.大肠杆菌O157:H7感染后抗生素治疗引发溶血尿毒综合征的风险。
N Engl J Med. 2000 Oct 26;343(17):1271; author reply 1272-3.
4
Risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections.大肠杆菌O157:H7感染抗生素治疗后溶血尿毒综合征的风险。
N Engl J Med. 2000 Oct 26;343(17):1271-2; author reply 1272-3. doi: 10.1056/NEJM200010263431716.
5
E. coli, antibiotics and hemolytic-uremic syndrome in children.儿童中的大肠杆菌、抗生素与溶血尿毒综合征
CMAJ. 2000 Aug 22;163(4):438.
6
E. coli, antibiotics, and the hemolytic-uremic syndrome.大肠杆菌、抗生素与溶血尿毒综合征
N Engl J Med. 2000 Jun 29;342(26):1990-1. doi: 10.1056/NEJM200006293422611.
7
Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.大肠杆菌O157:H7感染期间的相对肾脏保护作用：与静脉补液扩容的关系
Pediatrics. 2005 Jun;115(6):e673-80. doi: 10.1542/peds.2004-2236.
8
Antibiotic treatment of Escherichia coli O157 infection and the risk of hemolytic uremic syndrome, Minnesota.大肠杆菌 O157 感染的抗生素治疗与溶血尿毒综合征的风险，明尼苏达州。
Pediatr Infect Dis J. 2012 Jan;31(1):37-41. doi: 10.1097/INF.0b013e31823096a8.
9
Antimotility agents and E. coli infection.止泻剂与大肠杆菌感染
CMAJ. 1999 Apr 6;160(7):984, 986.
10
The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections.大肠杆菌O157:H7感染抗生素治疗后溶血尿毒综合征的风险。
N Engl J Med. 2000 Jun 29;342(26):1930-6. doi: 10.1056/NEJM200006293422601.
本文引用的文献
1
E. coli, antibiotics and hemolytic-uremic syndrome in children.儿童中的大肠杆菌、抗生素与溶血尿毒综合征
CMAJ. 2000 Aug 22;163(4):438.
2
The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections.大肠杆菌O157:H7感染抗生素治疗后溶血尿毒综合征的风险。
N Engl J Med. 2000 Jun 29;342(26):1930-6. doi: 10.1056/NEJM200006293422601.
3
Strain-specific differences in the amount of Shiga toxin released from enterohemorrhagic Escherichia coli O157 following exposure to subinhibitory concentrations of antimicrobial agents.肠出血性大肠杆菌O157在接触亚抑菌浓度抗菌剂后释放的志贺毒素量的菌株特异性差异。
Eur J Clin Microbiol Infect Dis. 1998 Nov;17(11):761-6. doi: 10.1007/s100960050181.
4
Predictors of hemolytic uremic syndrome in children during a large outbreak of Escherichia coli O157:H7 infections.大肠杆菌O157:H7感染大规模暴发期间儿童溶血尿毒综合征的预测因素
Pediatrics. 1997 Jul;100(1):E12. doi: 10.1542/peds.100.1.e12.
5
6
A severe outbreak of Escherichia coli O157:H7--associated hemorrhagic colitis in a nursing home.一家养老院中发生的与大肠杆菌O157:H7相关的严重出血性结肠炎疫情。
N Engl J Med. 1987 Dec 10;317(24):1496-500. doi: 10.1056/NEJM198712103172403.
7
Risk factors for development of hemolytic uremic syndrome during shigellosis.
J Pediatr. 1987 Jun;110(6):894-7. doi: 10.1016/s0022-3476(87)80405-5.
8
Antibiotics for Escherichia coli O157: H7 enteritis?用于治疗大肠杆菌O157：H7肠炎的抗生素？
J Antimicrob Chemother. 1989 May;23(5):807-8. doi: 10.1093/jac/23.5.807.
9
Risk factors for the progression of Escherichia coli O157:H7 enteritis to hemolytic-uremic syndrome.
J Pediatr. 1990 Apr;116(4):589-92. doi: 10.1016/s0022-3476(05)81609-9.
10
Randomized, controlled trial of antibiotic therapy for Escherichia coli O157:H7 enteritis.
J Pediatr. 1992 Aug;121(2):299-303. doi: 10.1016/s0022-3476(05)81209-0.
Zotero 插件